Food and Drug Administration Approval of BuprenorphineNaloxone for Office Treatment of Addiction
Open Access
- 18 February 2003
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 138 (4) , 360
- https://doi.org/10.7326/0003-4819-138-4-200302180-00027
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Opioid Dependence Treatment, Including Buprenorphine/NaloxoneAnnals of Pharmacotherapy, 2002
- Buprenorphine Treatment of Heroin Dependence (Detoxification and Maintenance) in a Private Practice SettingJournal of Addictive Diseases, 2001
- Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine–naloxone tabletDrug and Alcohol Dependence, 1999
- Effects of buprenorphine and naloxone in morphine-stabilized opioid addictsDrug and Alcohol Dependence, 1998